A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

Overview of attention for article published in International Journal of Hematology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 14,847 followers.

A phase II study of #Revlimid consolidation and maintenance therapy after autologous PBSCT in patients with multiple #myeloma shows overall response rates after consolidation and maintenance therapies of 73.7% and 81.6%, respectively: https://t.co/ljXUly5L

06 Oct 2018

Reply Repost Favourite